Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Massi

Showing results (271-280 of 357) with videos related to

Pageof 36
Sort By:
Cancers|April 13, 2024
Dermoscopy as a Tool for Identifying Potentially Metastatic Thin Melanoma: A Clinical-Dermoscopic and Histopathological Case-Control StudyVincenzo De Giorgi, Flavia Silvestri, Giovanni Cecchi, et al.
Journal of the American Academy of Dermatology|May 18, 2016
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitorsAnna Falanga, Marina Marchetti, Daniela Massi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 casesBeatrice Vergier, Martina Prochazkova-Carlotti, Arnaud de la Fouchardière, et al.
Journal of Translational Medicine|August 31, 2013
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanomaMaria Colombino, Amelia Lissia, Mariaelena Capone, et al.
Pathology, Research and Practice|October 13, 2023
Prognosis of naevoid melanomasMartin G Cook, Megan Grant, Yvonne Sylvestre, et al.
Cells|November 27, 2021
The TRPA1 Channel Amplifies the Oxidative Stress Signal in MelanomaFrancesco De Logu, Daniel Souza Monteiro de Araujo, Filippo Ugolini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 19, 2026
Physical activity is associated with improved survival in skin cancer patients: A meta-analysisAlessandra Picelli, Aurora Gaeta, Chiara Doccioli, et al.
Clinical and Experimental Dermatology|February 6, 2022
Atypical Spitz tumours: an epidemiological, clinical and dermoscopic multicentre study with 16 years of follow-upVincenzo De Giorgi, Federico Venturi, Flavia Silvestri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomasValeria Masciullo, Tommaso Susini, Alessandra Zamparelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2010
S100A13 is a new angiogenic marker in human melanomaDaniela Massi, Matteo Landriscina, Annamaria Piscazzi, et al.
Pageof 36

Showing results (271-280 of 357) with videos related to

Sort By:
Pageof 36
Cancers|April 13, 2024
Dermoscopy as a Tool for Identifying Potentially Metastatic Thin Melanoma: A Clinical-Dermoscopic and Histopathological Case-Control StudyVincenzo De Giorgi, Flavia Silvestri, Giovanni Cecchi, et al.
Journal of the American Academy of Dermatology|May 18, 2016
Thrombophilic status may predict prognosis in patients with metastatic BRAFV600-mutated melanoma who are receiving BRAF inhibitorsAnna Falanga, Marina Marchetti, Daniela Massi, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 15, 2010
Fluorescence in situ hybridization, a diagnostic aid in ambiguous melanocytic tumors: European study of 113 casesBeatrice Vergier, Martina Prochazkova-Carlotti, Arnaud de la Fouchardière, et al.
Journal of Translational Medicine|August 31, 2013
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanomaMaria Colombino, Amelia Lissia, Mariaelena Capone, et al.
Pathology, Research and Practice|October 13, 2023
Prognosis of naevoid melanomasMartin G Cook, Megan Grant, Yvonne Sylvestre, et al.
Cells|November 27, 2021
The TRPA1 Channel Amplifies the Oxidative Stress Signal in MelanomaFrancesco De Logu, Daniel Souza Monteiro de Araujo, Filippo Ugolini, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|February 19, 2026
Physical activity is associated with improved survival in skin cancer patients: A meta-analysisAlessandra Picelli, Aurora Gaeta, Chiara Doccioli, et al.
Clinical and Experimental Dermatology|February 6, 2022
Atypical Spitz tumours: an epidemiological, clinical and dermoscopic multicentre study with 16 years of follow-upVincenzo De Giorgi, Federico Venturi, Flavia Silvestri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 14, 2003
Frequent loss of expression of the cyclin-dependent kinase inhibitor p27(Kip1) in estrogen-related Endometrial adenocarcinomasValeria Masciullo, Tommaso Susini, Alessandra Zamparelli, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 9, 2010
S100A13 is a new angiogenic marker in human melanomaDaniela Massi, Matteo Landriscina, Annamaria Piscazzi, et al.
Pageof 36